37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers  in vitro

Tyrone C. Otgaar; Eloise Ferreira; Sibusiso Malindisa; Martin Bernert; Boitelo T. Letsolo; Stefan F.T. Weiss

doi:10.18632/oncotarget.21278

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro

Tyrone C. Otgaar, Eloise Ferreira, Sibusiso Malindisa, Martin Bernert, Boitelo T. Letsolo and Stefan F.T. Weiss _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:86646-86656. https://doi.org/10.18632/oncotarget.21278

Metrics: PDF 1341 views | HTML 2760 views | ?

Abstract

Tyrone C. Otgaar1, Eloise Ferreira1, Sibusiso Malindisa1,2, Martin Bernert1, Boitelo T. Letsolo1 and Stefan F.T. Weiss1

1School of Molecular and Cell Biology, University of the Witwatersrand, Wits 2050, Republic of South Africa

2Present Address: Department of Life and Consumer Sciences, University of South Africa, Florida 1710, Republic of South Africa

Correspondence to:

Stefan F.T. Weiss, email: [email protected]

Keywords: aging, LRP/LR, LRP::FLAG, telomerase, telomeres

Received: June 30, 2017 Accepted: August 15, 2017 Published: September 27, 2017

ABSTRACT

One of the core regulators of cellular aging are telomeres, repetitive DNA sequences at the ends of chromosomes that are maintained by the ribonucleoprotein DNA polymerase complex, telomerase. Recently, we demonstrated that knockdown of the 37kDa/ 67kDa laminin receptor (LRP/LR), a protein that promotes cell viability in tumorigenic and normal cells, reduces telomerase activity. We therefore hypothesized that upregulating LRP/LR might increase telomerase activity and impede aging. Here we show that overexpression of LRP::FLAG resulted in significantly elevated hTERT levels, telomerase activity and telomere length, respectively, with concomitantly reduced levels of senescence markers. These data suggest a novel function of LRP/LR hampering the onset of senescence through elevating hTERT levels and telomerase activity, respectively. LRP::FLAG might therefore act as a potential novel anti-aging drug through the impediment of the cellular aging process.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21278

Publication Alerts

Post-Publication Promotion

Research Papers:

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro

Abstract